Covered recipient · General Payments record
GINGER MCMILLAN-BUCHANAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$750.14
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $152.80 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $34.79 | 2 |
| Abbott Laboratories | $29.69 | 2 |
| Otsuka America Pharmaceutical, Inc. | $21.55 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.25 | 1 |
| Amgen Inc. | $16.16 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.10 | 1 |
| Acerta Pharma LLC | $14.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.57 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124824489 | CMS |
| Abbott Laboratories | $15.12 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124824491 | CMS |
| ABBVIE INC. | $17.52 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107640422 | CMS |
| ABBVIE INC. | $17.27 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107640424 | CMS |
| Amgen Inc. | $16.16 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117626580 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.26 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105340337 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.10 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086364447 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.25 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117860327 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.55 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119135906 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.